Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients

M Bakker, JP Droz, AR Hanauske, Jaap Verweij, AT van Oosterom, HJM Groen, MA Pacciarini, L Domenigoni, F van Weissenbruch, E Pianezzola, EGE de Vries

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)139-146
Number of pages8
JournalBritish Journal of Cancer
Volume77
Issue number1
Publication statusPublished - 1998

Cite this